These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 31440052

  • 21. Propylene glycol-embodying deformable liposomes as a novel drug delivery carrier for vaginal fibrauretine delivery applications.
    Li WZ, Hao XL, Zhao N, Han WX, Zhai XF, Zhao Q, Wang YE, Zhou YQ, Cheng YC, Yue YH, Fu LN, Zhou JL, Wu HY, Dong CJ.
    J Control Release; 2016 Mar 28; 226():107-14. PubMed ID: 26883754
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H, Chhibber S, Harjai K.
    Int J Antimicrob Agents; 2015 Apr 28; 45(4):359-67. PubMed ID: 25604277
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Cationic amphipathic peptides KT2 and RT2 are taken up into bacterial cells and kill planktonic and biofilm bacteria.
    Anunthawan T, de la Fuente-Núñez C, Hancock RE, Klaynongsruang S.
    Biochim Biophys Acta; 2015 Jun 28; 1848(6):1352-8. PubMed ID: 25767037
    [Abstract] [Full Text] [Related]

  • 26. Fast Biofilm Penetration and Anti-PAO1 Activity of Nebulized Azithromycin in Nanoarchaeosomes.
    Altube MJ, Martínez MMB, Malheiros B, Maffía PC, Barbosa LRS, Morilla MJ, Romero EL.
    Mol Pharm; 2020 Jan 06; 17(1):70-83. PubMed ID: 31617725
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. In vitro susceptibility of urogenital Chlamydia trachomatis strains in a country with high azithromycin consumption rate.
    Ljubin-Sternak S, Mestrovic T, Vilibic-Cavlek T, Mlinaric-Galinovic G, Sviben M, Markotic A, Skerk V.
    Folia Microbiol (Praha); 2013 Sep 06; 58(5):361-5. PubMed ID: 23271498
    [Abstract] [Full Text] [Related]

  • 30. Liposomal Encapsulation Increases the Efficacy of Azithromycin against Chlamydia trachomatis.
    Bogdanov A, Janovák L, Vraneš J, Meštrović T, Ljubin-Sternak S, Cseh Z, Endrész V, Burián K, Vanić Ž, Virok DP.
    Pharmaceutics; 2021 Dec 24; 14(1):. PubMed ID: 35056934
    [Abstract] [Full Text] [Related]

  • 31. Clinical cure rates in subjects treated with azithromycin for community-acquired respiratory tract infections caused by azithromycin-susceptible or azithromycin-resistant Streptococcus pneumoniae: analysis of Phase 3 clinical trial data.
    Zhanel GG, Wolter KD, Calciu C, Hogan P, Low DE, Weiss K, Karlowsky JA.
    J Antimicrob Chemother; 2014 Oct 24; 69(10):2835-40. PubMed ID: 24920652
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Combinatorial liposomes of berberine and curcumin inhibit biofilm formation and intracellular methicillin resistant Staphylococcus aureus infections and associated inflammation.
    Bhatia E, Sharma S, Jadhav K, Banerjee R.
    J Mater Chem B; 2021 Jan 28; 9(3):864-875. PubMed ID: 33392614
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Novel vaginal drug delivery system: deformable propylene glycol liposomes-in-hydrogel.
    Vanić Ž, Hurler J, Ferderber K, Golja Gašparović P, Škalko-Basnet N, Filipović-Grčić J.
    J Liposome Res; 2014 Mar 28; 24(1):27-36. PubMed ID: 23931627
    [Abstract] [Full Text] [Related]

  • 36. The efficacy of different anti-microbial metals at preventing the formation of, and eradicating bacterial biofilms of pathogenic indicator strains.
    Gugala N, Lemire JA, Turner RJ.
    J Antibiot (Tokyo); 2017 Jun 28; 70(6):775-780. PubMed ID: 28196974
    [Abstract] [Full Text] [Related]

  • 37. [Efficacy and safety of azithromycin in the treatment of female genital Chlamydia trachomatis infections].
    Narcio Reyes LE, Casanova Roman G, Arredondo Garcia JL.
    Ginecol Obstet Mex; 1993 Sep 28; 61():261-4. PubMed ID: 8406112
    [Abstract] [Full Text] [Related]

  • 38. Glucosylated liposomes as drug delivery systems of usnic acid to address bacterial infections.
    Francolini I, Giansanti L, Piozzi A, Altieri B, Mauceri A, Mancini G.
    Colloids Surf B Biointerfaces; 2019 Sep 01; 181():632-638. PubMed ID: 31207445
    [Abstract] [Full Text] [Related]

  • 39. Role of biofilm formation in Ureaplasma antibiotic susceptibility and development of bronchopulmonary dysplasia in preterm neonates.
    Pandelidis K, McCarthy A, Chesko KL, Viscardi RM.
    Pediatr Infect Dis J; 2013 Apr 01; 32(4):394-8. PubMed ID: 23114371
    [Abstract] [Full Text] [Related]

  • 40. Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis.
    Deguchi T, Hatazaki K, Ito S, Kondo H, Horie K, Nakane K, Mizutani K, Tsuchiya T, Yasuda M, Yokoi S, Nakano M.
    J Infect Chemother; 2018 Aug 01; 24(8):610-614. PubMed ID: 29627327
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.